Track topics on Twitter Track topics that are important to you
Physicians Research Group (PRG) expands its Global Network of high performing clinical research sites and therapeutic research areas with the P3 Research Alliance. The PRG/P3 Strategic Alliance brings synergy to both organizations’ efforts to provide high-performing research sites to the biomedical world.
TEMPE, Ariz. (PRWEB) August 14, 2018
Physicians Research Group (PRG) announced, today, that it will partner with P3 Research Ltd of New Zealand to expand PRG’s Global Network of clinical research sites. As a result, PRG will be able to provide the biomedical, device and diagnostic industries with additional high-performing sites in several locations across New Zealand.
“It is with pride that P3 Research is developing a partnership with Physicians Research Group in order to facilitate and enhance opportunities for US based Biotech and Pharma to bring, in particular, early phase clinical trials to New Zealand. The acknowledged quality and experience of our three sites, coupled with a very smooth and efficient centralized regulatory/ethics process, makes P3 Research a very attractive provider of reliable, fast, efficient and high quality early phase studies in a variety of therapeutic areas. We look forward to growing our partnership with PRG for the benefit of the industry and patients alike.”
“The development of the partnership increases our capabilities to meet the needs of the growing global pharmaceutical marketplace,” said Robert Wallace, President and Chief Executive Officer of PRG. “We are elated about this partnership and the opportunity to highlight the elite clinical research services P3 Research provides. P3 has an impressive track record in managing clinical trials in New Zealand, and we see them as an ideal partner as we continue to expand our global operations.”
PRG is an international, multispecialty research management organization that connects physician investigators with sponsors, patients, coordination, and support needed to conduct clinical trials within their own practices. Conducting trials with PRG provides the most immediate and effective way to work on the forefront of medical research and discovery and provides access to cutting-edge therapies.
About P3 Research
P3 Research is a leader in NZ for conducting clinical trials for national and international sponsors. The Company was established in 2001 in Wellington but has since grown to include two further sites in Tauranga and Hawkes Bay. We have been involved in over 100 clinical trials since 2001 and specialize in phase 2 and 3 clinical trials in a wide variety of therapeutic areas which are normally managed in Primary care settings. Our overnight, single room, facilities in the Wellington unit make it ideal for the conduct of early phase studies.
For the original version on PRWeb visit: https://www.prweb.com/releases/physicians_research_group_announces_strategic_alliance_with_p3_research_ltd_of_new_zealand/prweb15675105.htmNEXT ARTICLE
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.